For years PBMs have been assailed by pharma companies and Congress, and the new Trump administration looks likely to keep up the barrage.
CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But ...
The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the ...
A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.
As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
A giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...
the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx. It concludes that the PBMs generated $7.3 billion by marking up drugs in these ...